![Scott Mendel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Scott Mendel
Directeur/Bestuurslid bij AKOYA BIOSCIENCES, INC.
Vermogen: 276 876 $ op 31-05-2024
Actieve functies van Scott Mendel
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AKOYA BIOSCIENCES, INC. | Directeur/Bestuurslid | 11-06-2021 | - |
Independent Dir/Board Member | 11-06-2021 | - | |
QUANTUM-SI INCORPORATED | Directeur/Bestuurslid | 15-05-2023 | - |
Visby Medical, Inc.
![]() Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | Directeur/Bestuurslid | 04-01-2022 | - |
Agendia, Inc.
![]() Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Directeur/Bestuurslid | 06-01-2022 | - |
Loopbaan van Scott Mendel
Eerdere bekende functies van Scott Mendel
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ACTIVE NETWORK INC | Financieel Directeur/CFO | 01-03-2010 | 01-12-2013 |
GE AEROSPACE | Corporate Officer/Principal | 01-03-2003 | 01-03-2010 |
GENMARK DIAGNOSTICS, INC. | Comptroller/Controller/Auditor | 13-05-2014 | 18-02-2019 |
Directeur/Bestuurslid | 02-05-2020 | 22-04-2021 | |
Algemeen Directeur | 10-02-2020 | - | |
Operationeel Directeur | 18-02-2019 | 02-05-2020 | |
Financieel Directeur/CFO | 13-05-2014 | 18-02-2019 | |
President | 10-02-2020 | - |
Opleiding van Scott Mendel
Indiana University | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 10 |
Operationeel
Director/Board Member | 5 |
Director of Finance/CFO | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 5 |
Technology Services | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
GE AEROSPACE | Producer Manufacturing |
AKOYA BIOSCIENCES, INC. | Health Technology |
QUANTUM-SI INCORPORATED | Technology Services |
Bedrijven in privébezit | 4 |
---|---|
Active Network LLC
![]() Active Network LLC Packaged SoftwareTechnology Services Active Network LLC engages in cloud based activity and participant management solutions. It offers software solutions for race management, recreation management, outdoor management, camp management, church management, ski and attractions, sports management, school management, and swim management. The company was founded by Scott Galen Kyle, Mitchell F. Thrower, David Alberga, and Jim Woodman in 1999 and is headquartered in Dallas, TX. | Technology Services |
GenMark Diagnostics, Inc.
![]() GenMark Diagnostics, Inc. Medical SpecialtiesHealth Technology GenMark Diagnostics, Inc. engages in the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary eSensor detection technology. Its solutions include ePlex System and XT-8 System. The company was founded by Jon Faiz Kayyem in 1993 and is headquartered in Carlsbad, CA. | Health Technology |
Visby Medical, Inc.
![]() Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | Health Technology |
Agendia, Inc.
![]() Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
- Beurs
- Insiders
- Scott Mendel
- Ervaring